Sun, Nov 23, 2014, 8:34 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Agenus Inc. Message Board

  • kenrp713 kenrp713 Aug 26, 2012 6:58 PM Flag

    What is QS-21 worth if GSK only bought QS-21?

    Valuation - thoughts anyone?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • GSK has another adjuvant, MPL, which they acquired when they bought out Corixa...for 300 million.
      MPL and QS-21 are in Bill Gates' Malaria Vaccine. That vaccine did not work until they added QS-21 to it.
      QS-21 is in three other vaccines made by GSK in Phase 3 development.
      It is in at least 12 other vaccines in clinical trials, also.
      I would think QS-21 is worth 400 million which would give us a share price of 16.00.
      ...and, here we sit at 4.50.

      • 1 Reply to bmcgoo_03
      • Interesting. I found where the CEO, Armen Garo, in a webcast on AGEN's website on October 21st stated future projections of peak sales on QS-21 of "hundreds of millions of dollars" annually. I was thinking $200 million (one years' annual sales) X 5X's sales = $1 billion. But what do I know.

        I like hearing everyone's opinions and getting good solid information about companies. It seems GSK protected their investment by purchasing a "First Right to Negotiate". I am interested in hearing as many valuations as possible. Any more thoughts out there?

2.93-0.04(-1.35%)Nov 21 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
GameStop Corp.
NYSEFri, Nov 21, 2014 4:04 PM EST
Intuit Inc.
NasdaqGSFri, Nov 21, 2014 4:00 PM EST